TCRT:NASDAQAlaunos Therapeutics, Inc. Analysis
Data as of 2026-09-08 - not real-time
$1.57
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Alaunos Therapeutics, Inc. is priced at $1.57 and its moving averages line up in bearish order, the shorter trailing the longer. Over a rolling month the price has lost 18.7%. With RSI at 29.4 the momentum picture is oversold, alongside a bearish MACD signal. The recent range runs from support at $1.55 up to resistance at $2.05.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 42.1%, a beta of 1.24 and a maximum drawdown of 64.0%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on sell — conviction 4 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 42.1%, a beta of 1.24 and a maximum drawdown of 64.0%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on sell — conviction 4 out of 10.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked below long-term ones
- RSI at 29.4 signals oversold conditions
- Trading below the 200-day average of 2.69
Medium Term
1–3 yearsCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- RSI at 29.4 signals oversold conditions
- Trading below the 200-day average of 2.69
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Negative return on equity of -185.9%
- Negative free cash flow
- 30-day volatility of 42.1%
Key Metrics & Analysis
Financial Health
P/E Ratio-2.6
ROE-185.95%
ROA-81.13%
P/B Ratio2.9
Op. Cash Flow$-2727000
Free Cash Flow$-1570625
Industry P/E29.9
Technical Analysis
TrendBearish
RSI29.4
Support$1.55
Resistance$2.05
MA 20$1.78
MA 50$1.93
MA 200$2.69
MACDBearish
VolumeStable
Fear & Greed Index93.36
Valuation
GradeFair
TypeBlend
Risk Assessment
Beta1.24
Volatility42.11%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.